The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biothrax (Anthrax Vaccine) Market Research Report 2025
Synopsis
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax. Biothrax, commonly known as the anthrax vaccine, is a medical countermeasure developed to protect individuals from anthrax, a potentially lethal bacterial infection caused by Bacillus anthracis. The vaccine is used primarily for military personnel, laboratory workers, and individuals at high risk of exposure to anthrax spores. It stimulates the immune system to produce antibodies against the anthrax toxin, preventing the progression of the disease if exposed to the bacteria. Biothrax is administered through a series of doses and boosters and is a critical component of preparedness against bioterrorism threats involving anthrax.
The global Biothrax (Anthrax Vaccine) market was valued at US$ 655 million in 2023 and is anticipated to reach US$ 1059.2 million by 2030, witnessing a CAGR of 7.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biothrax (Anthrax Vaccine), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biothrax (Anthrax Vaccine).
Report Scope
The Biothrax (Anthrax Vaccine) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biothrax (Anthrax Vaccine) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biothrax (Anthrax Vaccine) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
Segment by Type
Live Vaccines
Cell Free PA Vaccines
Segment by Application
Human Use
Animal Use
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biothrax (Anthrax Vaccine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biothrax (Anthrax Vaccine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax. Biothrax, commonly known as the anthrax vaccine, is a medical countermeasure developed to protect individuals from anthrax, a potentially lethal bacterial infection caused by Bacillus anthracis. The vaccine is used primarily for military personnel, laboratory workers, and individuals at high risk of exposure to anthrax spores. It stimulates the immune system to produce antibodies against the anthrax toxin, preventing the progression of the disease if exposed to the bacteria. Biothrax is administered through a series of doses and boosters and is a critical component of preparedness against bioterrorism threats involving anthrax.
The global Biothrax (Anthrax Vaccine) market was valued at US$ 655 million in 2023 and is anticipated to reach US$ 1059.2 million by 2030, witnessing a CAGR of 7.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biothrax (Anthrax Vaccine), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biothrax (Anthrax Vaccine).
Report Scope
The Biothrax (Anthrax Vaccine) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biothrax (Anthrax Vaccine) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biothrax (Anthrax Vaccine) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
Segment by Type
Live Vaccines
Cell Free PA Vaccines
Segment by Application
Human Use
Animal Use
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biothrax (Anthrax Vaccine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biothrax (Anthrax Vaccine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Biothrax (Anthrax Vaccine) Market Overview
1.1 Product Overview and Scope of Biothrax (Anthrax Vaccine)
1.2 Biothrax (Anthrax Vaccine) Segment by Type
1.2.1 Global Biothrax (Anthrax Vaccine) Market Value Comparison by Type (2024-2030)
1.2.2 Live Vaccines
1.2.3 Cell Free PA Vaccines
1.3 Biothrax (Anthrax Vaccine) Segment by Application
1.3.1 Global Biothrax (Anthrax Vaccine) Market Value by Application: (2024-2030)
1.3.2 Human Use
1.3.3 Animal Use
1.4 Global Biothrax (Anthrax Vaccine) Market Size Estimates and Forecasts
1.4.1 Global Biothrax (Anthrax Vaccine) Revenue 2019-2030
1.4.2 Global Biothrax (Anthrax Vaccine) Sales 2019-2030
1.4.3 Global Biothrax (Anthrax Vaccine) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Biothrax (Anthrax Vaccine) Market Competition by Manufacturers
2.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Biothrax (Anthrax Vaccine) Average Price by Manufacturers (2019-2024)
2.4 Global Biothrax (Anthrax Vaccine) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biothrax (Anthrax Vaccine), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biothrax (Anthrax Vaccine), Product Type & Application
2.7 Biothrax (Anthrax Vaccine) Market Competitive Situation and Trends
2.7.1 Biothrax (Anthrax Vaccine) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biothrax (Anthrax Vaccine) Players Market Share by Revenue
2.7.3 Global Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biothrax (Anthrax Vaccine) Retrospective Market Scenario by Region
3.1 Global Biothrax (Anthrax Vaccine) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Biothrax (Anthrax Vaccine) Global Biothrax (Anthrax Vaccine) Sales by Region: 2019-2030
3.2.1 Global Biothrax (Anthrax Vaccine) Sales by Region: 2019-2024
3.2.2 Global Biothrax (Anthrax Vaccine) Sales by Region: 2025-2030
3.3 Global Biothrax (Anthrax Vaccine) Global Biothrax (Anthrax Vaccine) Revenue by Region: 2019-2030
3.3.1 Global Biothrax (Anthrax Vaccine) Revenue by Region: 2019-2024
3.3.2 Global Biothrax (Anthrax Vaccine) Revenue by Region: 2025-2030
3.4 North America Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.4.1 North America Biothrax (Anthrax Vaccine) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Biothrax (Anthrax Vaccine) Sales by Country (2019-2030)
3.4.3 North America Biothrax (Anthrax Vaccine) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.5.1 Europe Biothrax (Anthrax Vaccine) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Biothrax (Anthrax Vaccine) Sales by Country (2019-2030)
3.5.3 Europe Biothrax (Anthrax Vaccine) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.6.1 Asia Pacific Biothrax (Anthrax Vaccine) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Biothrax (Anthrax Vaccine) Sales by Country (2019-2030)
3.6.3 Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.7.1 Latin America Biothrax (Anthrax Vaccine) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Biothrax (Anthrax Vaccine) Sales by Country (2019-2030)
3.7.3 Latin America Biothrax (Anthrax Vaccine) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.8.1 Middle East and Africa Biothrax (Anthrax Vaccine) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Biothrax (Anthrax Vaccine) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biothrax (Anthrax Vaccine) Sales by Type (2019-2030)
4.1.1 Global Biothrax (Anthrax Vaccine) Sales by Type (2019-2024)
4.1.2 Global Biothrax (Anthrax Vaccine) Sales by Type (2025-2030)
4.1.3 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2019-2030)
4.2 Global Biothrax (Anthrax Vaccine) Revenue by Type (2019-2030)
4.2.1 Global Biothrax (Anthrax Vaccine) Revenue by Type (2019-2024)
4.2.2 Global Biothrax (Anthrax Vaccine) Revenue by Type (2025-2030)
4.2.3 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2019-2030)
4.3 Global Biothrax (Anthrax Vaccine) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Biothrax (Anthrax Vaccine) Sales by Application (2019-2030)
5.1.1 Global Biothrax (Anthrax Vaccine) Sales by Application (2019-2024)
5.1.2 Global Biothrax (Anthrax Vaccine) Sales by Application (2025-2030)
5.1.3 Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2019-2030)
5.2 Global Biothrax (Anthrax Vaccine) Revenue by Application (2019-2030)
5.2.1 Global Biothrax (Anthrax Vaccine) Revenue by Application (2019-2024)
5.2.2 Global Biothrax (Anthrax Vaccine) Revenue by Application (2025-2030)
5.2.3 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2019-2030)
5.3 Global Biothrax (Anthrax Vaccine) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merial
6.1.1 Merial Corporation Information
6.1.2 Merial Description and Business Overview
6.1.3 Merial Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merial Biothrax (Anthrax Vaccine) Product Portfolio
6.1.5 Merial Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Biothrax (Anthrax Vaccine) Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Corporation Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zoetis Biothrax (Anthrax Vaccine) Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Bayer Sanidad Animal
6.4.1 Bayer Sanidad Animal Corporation Information
6.4.2 Bayer Sanidad Animal Description and Business Overview
6.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Portfolio
6.4.5 Bayer Sanidad Animal Recent Developments/Updates
6.5 Colorado Serum
6.5.1 Colorado Serum Corporation Information
6.5.2 Colorado Serum Description and Business Overview
6.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Colorado Serum Biothrax (Anthrax Vaccine) Product Portfolio
6.5.5 Colorado Serum Recent Developments/Updates
6.6 PharmAthene
6.6.1 PharmAthene Corporation Information
6.6.2 PharmAthene Description and Business Overview
6.6.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 PharmAthene Biothrax (Anthrax Vaccine) Product Portfolio
6.6.5 PharmAthene Recent Developments/Updates
6.7 Tiankang
6.6.1 Tiankang Corporation Information
6.6.2 Tiankang Description and Business Overview
6.6.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tiankang Biothrax (Anthrax Vaccine) Product Portfolio
6.7.5 Tiankang Recent Developments/Updates
6.8 Biogénesis-Bago
6.8.1 Biogénesis-Bago Corporation Information
6.8.2 Biogénesis-Bago Description and Business Overview
6.8.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Portfolio
6.8.5 Biogénesis-Bago Recent Developments/Updates
6.9 CAVAC
6.9.1 CAVAC Corporation Information
6.9.2 CAVAC Description and Business Overview
6.9.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CAVAC Biothrax (Anthrax Vaccine) Product Portfolio
6.9.5 CAVAC Recent Developments/Updates
6.10 Rosenbusch
6.10.1 Rosenbusch Corporation Information
6.10.2 Rosenbusch Description and Business Overview
6.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Rosenbusch Biothrax (Anthrax Vaccine) Product Portfolio
6.10.5 Rosenbusch Recent Developments/Updates
6.11 Agrovet
6.11.1 Agrovet Corporation Information
6.11.2 Agrovet Biothrax (Anthrax Vaccine) Description and Business Overview
6.11.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Agrovet Biothrax (Anthrax Vaccine) Product Portfolio
6.11.5 Agrovet Recent Developments/Updates
6.12 Vecol
6.12.1 Vecol Corporation Information
6.12.2 Vecol Biothrax (Anthrax Vaccine) Description and Business Overview
6.12.3 Vecol Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Vecol Biothrax (Anthrax Vaccine) Product Portfolio
6.12.5 Vecol Recent Developments/Updates
6.13 CVCRI
6.13.1 CVCRI Corporation Information
6.13.2 CVCRI Biothrax (Anthrax Vaccine) Description and Business Overview
6.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CVCRI Biothrax (Anthrax Vaccine) Product Portfolio
6.13.5 CVCRI Recent Developments/Updates
6.14 IVPM
6.14.1 IVPM Corporation Information
6.14.2 IVPM Biothrax (Anthrax Vaccine) Description and Business Overview
6.14.3 IVPM Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 IVPM Biothrax (Anthrax Vaccine) Product Portfolio
6.14.5 IVPM Recent Developments/Updates
6.15 Prondil
6.15.1 Prondil Corporation Information
6.15.2 Prondil Biothrax (Anthrax Vaccine) Description and Business Overview
6.15.3 Prondil Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Prondil Biothrax (Anthrax Vaccine) Product Portfolio
6.15.5 Prondil Recent Developments/Updates
6.16 CDV
6.16.1 CDV Corporation Information
6.16.2 CDV Biothrax (Anthrax Vaccine) Description and Business Overview
6.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.16.4 CDV Biothrax (Anthrax Vaccine) Product Portfolio
6.16.5 CDV Recent Developments/Updates
6.17 Indian Immunologicals
6.17.1 Indian Immunologicals Corporation Information
6.17.2 Indian Immunologicals Biothrax (Anthrax Vaccine) Description and Business Overview
6.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Portfolio
6.17.5 Indian Immunologicals Recent Developments/Updates
6.18 Botswana Vaccine Institute
6.18.1 Botswana Vaccine Institute Corporation Information
6.18.2 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Description and Business Overview
6.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Portfolio
6.18.5 Botswana Vaccine Institute Recent Developments/Updates
6.19 Ceva Santé Animale
6.19.1 Ceva Santé Animale Corporation Information
6.19.2 Ceva Santé Animale Biothrax (Anthrax Vaccine) Description and Business Overview
6.19.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Portfolio
6.19.5 Ceva Santé Animale Recent Developments/Updates
6.20 Intervac
6.20.1 Intervac Corporation Information
6.20.2 Intervac Biothrax (Anthrax Vaccine) Description and Business Overview
6.20.3 Intervac Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Intervac Biothrax (Anthrax Vaccine) Product Portfolio
6.20.5 Intervac Recent Developments/Updates
6.21 JOVAC
6.21.1 JOVAC Corporation Information
6.21.2 JOVAC Biothrax (Anthrax Vaccine) Description and Business Overview
6.21.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.21.4 JOVAC Biothrax (Anthrax Vaccine) Product Portfolio
6.21.5 JOVAC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biothrax (Anthrax Vaccine) Industry Chain Analysis
7.2 Biothrax (Anthrax Vaccine) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biothrax (Anthrax Vaccine) Production Mode & Process
7.4 Biothrax (Anthrax Vaccine) Sales and Marketing
7.4.1 Biothrax (Anthrax Vaccine) Sales Channels
7.4.2 Biothrax (Anthrax Vaccine) Distributors
7.5 Biothrax (Anthrax Vaccine) Customers
8 Biothrax (Anthrax Vaccine) Market Dynamics
8.1 Biothrax (Anthrax Vaccine) Industry Trends
8.2 Biothrax (Anthrax Vaccine) Market Drivers
8.3 Biothrax (Anthrax Vaccine) Market Challenges
8.4 Biothrax (Anthrax Vaccine) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Biothrax (Anthrax Vaccine) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Biothrax (Anthrax Vaccine) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Biothrax (Anthrax Vaccine) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Biothrax (Anthrax Vaccine) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Biothrax (Anthrax Vaccine) Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Biothrax (Anthrax Vaccine), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Biothrax (Anthrax Vaccine), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Biothrax (Anthrax Vaccine), Product Type & Application
Table 12. Global Key Manufacturers of Biothrax (Anthrax Vaccine), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biothrax (Anthrax Vaccine) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biothrax (Anthrax Vaccine) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biothrax (Anthrax Vaccine) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Biothrax (Anthrax Vaccine) Sales by Region (2019-2024) & (K Units)
Table 18. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2019-2024)
Table 19. Global Biothrax (Anthrax Vaccine) Sales by Region (2025-2030) & (K Units)
Table 20. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2025-2030)
Table 21. Global Biothrax (Anthrax Vaccine) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2019-2024)
Table 23. Global Biothrax (Anthrax Vaccine) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2025-2030)
Table 25. North America Biothrax (Anthrax Vaccine) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Biothrax (Anthrax Vaccine) Sales by Country (2019-2024) & (K Units)
Table 27. North America Biothrax (Anthrax Vaccine) Sales by Country (2025-2030) & (K Units)
Table 28. North America Biothrax (Anthrax Vaccine) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Biothrax (Anthrax Vaccine) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Biothrax (Anthrax Vaccine) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Biothrax (Anthrax Vaccine) Sales by Country (2019-2024) & (K Units)
Table 32. Europe Biothrax (Anthrax Vaccine) Sales by Country (2025-2030) & (K Units)
Table 33. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Biothrax (Anthrax Vaccine) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Biothrax (Anthrax Vaccine) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Biothrax (Anthrax Vaccine) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Biothrax (Anthrax Vaccine) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Biothrax (Anthrax Vaccine) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Biothrax (Anthrax Vaccine) Sales (K Units) by Type (2019-2024)
Table 51. Global Biothrax (Anthrax Vaccine) Sales (K Units) by Type (2025-2030)
Table 52. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2019-2024)
Table 53. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2025-2030)
Table 54. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2019-2024)
Table 57. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2025-2030)
Table 58. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Type (2019-2024)
Table 59. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Type (2025-2030)
Table 60. Global Biothrax (Anthrax Vaccine) Sales (K Units) by Application (2019-2024)
Table 61. Global Biothrax (Anthrax Vaccine) Sales (K Units) by Application (2025-2030)
Table 62. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2019-2024)
Table 63. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2025-2030)
Table 64. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2019-2024)
Table 67. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2025-2030)
Table 68. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Application (2019-2024)
Table 69. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Application (2025-2030)
Table 70. Merial Corporation Information
Table 71. Merial Description and Business Overview
Table 72. Merial Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Merial Biothrax (Anthrax Vaccine) Product
Table 74. Merial Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Merck Biothrax (Anthrax Vaccine) Product
Table 79. Merck Recent Developments/Updates
Table 80. Zoetis Corporation Information
Table 81. Zoetis Description and Business Overview
Table 82. Zoetis Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Zoetis Biothrax (Anthrax Vaccine) Product
Table 84. Zoetis Recent Developments/Updates
Table 85. Bayer Sanidad Animal Corporation Information
Table 86. Bayer Sanidad Animal Description and Business Overview
Table 87. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product
Table 89. Bayer Sanidad Animal Recent Developments/Updates
Table 90. Colorado Serum Corporation Information
Table 91. Colorado Serum Description and Business Overview
Table 92. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Colorado Serum Biothrax (Anthrax Vaccine) Product
Table 94. Colorado Serum Recent Developments/Updates
Table 95. PharmAthene Corporation Information
Table 96. PharmAthene Description and Business Overview
Table 97. PharmAthene Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. PharmAthene Biothrax (Anthrax Vaccine) Product
Table 99. PharmAthene Recent Developments/Updates
Table 100. Tiankang Corporation Information
Table 101. Tiankang Description and Business Overview
Table 102. Tiankang Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Tiankang Biothrax (Anthrax Vaccine) Product
Table 104. Tiankang Recent Developments/Updates
Table 105. Biogénesis-Bago Corporation Information
Table 106. Biogénesis-Bago Description and Business Overview
Table 107. Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Biogénesis-Bago Biothrax (Anthrax Vaccine) Product
Table 109. Biogénesis-Bago Recent Developments/Updates
Table 110. CAVAC Corporation Information
Table 111. CAVAC Description and Business Overview
Table 112. CAVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. CAVAC Biothrax (Anthrax Vaccine) Product
Table 114. CAVAC Recent Developments/Updates
Table 115. Rosenbusch Corporation Information
Table 116. Rosenbusch Description and Business Overview
Table 117. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Rosenbusch Biothrax (Anthrax Vaccine) Product
Table 119. Rosenbusch Recent Developments/Updates
Table 120. Agrovet Corporation Information
Table 121. Agrovet Description and Business Overview
Table 122. Agrovet Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Agrovet Biothrax (Anthrax Vaccine) Product
Table 124. Agrovet Recent Developments/Updates
Table 125. Vecol Corporation Information
Table 126. Vecol Description and Business Overview
Table 127. Vecol Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Vecol Biothrax (Anthrax Vaccine) Product
Table 129. Vecol Recent Developments/Updates
Table 130. CVCRI Corporation Information
Table 131. CVCRI Description and Business Overview
Table 132. CVCRI Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. CVCRI Biothrax (Anthrax Vaccine) Product
Table 134. CVCRI Recent Developments/Updates
Table 135. IVPM Corporation Information
Table 136. IVPM Description and Business Overview
Table 137. IVPM Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. IVPM Biothrax (Anthrax Vaccine) Product
Table 139. IVPM Recent Developments/Updates
Table 140. Prondil Corporation Information
Table 141. Prondil Description and Business Overview
Table 142. Prondil Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Prondil Biothrax (Anthrax Vaccine) Product
Table 144. Prondil Recent Developments/Updates
Table 145. CDV Corporation Information
Table 146. CDV Description and Business Overview
Table 147. CDV Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. CDV Biothrax (Anthrax Vaccine) Product
Table 149. CDV Recent Developments/Updates
Table 150. Indian Immunologicals Corporation Information
Table 151. Indian Immunologicals Description and Business Overview
Table 152. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Indian Immunologicals Biothrax (Anthrax Vaccine) Product
Table 154. Indian Immunologicals Recent Developments/Updates
Table 155. Botswana Vaccine Institute Corporation Information
Table 156. Botswana Vaccine Institute Description and Business Overview
Table 157. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product
Table 159. Botswana Vaccine Institute Recent Developments/Updates
Table 160. Ceva Santé Animale Corporation Information
Table 161. Ceva Santé Animale Description and Business Overview
Table 162. Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Ceva Santé Animale Biothrax (Anthrax Vaccine) Product
Table 164. Ceva Santé Animale Recent Developments/Updates
Table 165. Intervac Corporation Information
Table 166. Intervac Description and Business Overview
Table 167. Intervac Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Intervac Biothrax (Anthrax Vaccine) Product
Table 169. Intervac Recent Developments/Updates
Table 170. JOVAC Corporation Information
Table 171. JOVAC Description and Business Overview
Table 172. JOVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. JOVAC Biothrax (Anthrax Vaccine) Product
Table 174. JOVAC Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Biothrax (Anthrax Vaccine) Distributors List
Table 178. Biothrax (Anthrax Vaccine) Customers List
Table 179. Biothrax (Anthrax Vaccine) Market Trends
Table 180. Biothrax (Anthrax Vaccine) Market Drivers
Table 181. Biothrax (Anthrax Vaccine) Market Challenges
Table 182. Biothrax (Anthrax Vaccine) Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biothrax (Anthrax Vaccine)
Figure 2. Global Biothrax (Anthrax Vaccine) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Biothrax (Anthrax Vaccine) Market Share by Type in 2023 & 2030
Figure 4. Live Vaccines Product Picture
Figure 5. Cell Free PA Vaccines Product Picture
Figure 6. Global Biothrax (Anthrax Vaccine) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Biothrax (Anthrax Vaccine) Market Share by Application in 2023 & 2030
Figure 8. Human Use
Figure 9. Animal Use
Figure 10. Global Biothrax (Anthrax Vaccine) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Biothrax (Anthrax Vaccine) Market Size (2019-2030) & (US$ Million)
Figure 12. Global Biothrax (Anthrax Vaccine) Sales (2019-2030) & (K Units)
Figure 13. Global Biothrax (Anthrax Vaccine) Average Price (US$/Unit) & (2019-2030)
Figure 14. Biothrax (Anthrax Vaccine) Report Years Considered
Figure 15. Biothrax (Anthrax Vaccine) Sales Share by Manufacturers in 2023
Figure 16. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Biothrax (Anthrax Vaccine) Players: Market Share by Revenue in 2023
Figure 18. Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Biothrax (Anthrax Vaccine) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Biothrax (Anthrax Vaccine) Sales Market Share by Country (2019-2030)
Figure 21. North America Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2019-2030)
Figure 22. United States Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country (2019-2030)
Figure 25. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2019-2030)
Figure 26. Germany Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2019-2030)
Figure 33. China Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Biothrax (Anthrax Vaccine) Sales Market Share by Country (2019-2030)
Figure 43. Latin America Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Biothrax (Anthrax Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Biothrax (Anthrax Vaccine) by Type (2019-2030)
Figure 53. Global Revenue Market Share of Biothrax (Anthrax Vaccine) by Type (2019-2030)
Figure 54. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Biothrax (Anthrax Vaccine) by Application (2019-2030)
Figure 56. Global Revenue Market Share of Biothrax (Anthrax Vaccine) by Application (2019-2030)
Figure 57. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Application (2019-2030)
Figure 58. Biothrax (Anthrax Vaccine) Value Chain
Figure 59. Biothrax (Anthrax Vaccine) Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
